XENETIC BIOSCIENCES, INC. Goodwill
XENETIC BIOSCIENCES, INC. (XBIO) had Goodwill of $0 as of 2021-03-31, per its 10-Q filed 2021-05-11.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:Goodwill · last filed 2022-03-22
- 2021-03-31: Goodwill $0.00.
- 2020-12-31: Goodwill $0.00; Goodwill as first filed $9.24M.
- 2020-09-30: Goodwill $0.00.
- 2019-12-31: Goodwill $9.24M; Goodwill as first filed $0.00.
| Period end | Goodwill | Goodwill as first filed |
|---|---|---|
| 2021-03-31 | $0.00 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $0.00 10-K · filed 2022-03-22 | $9.24M 10-Q · filed 2021-05-11 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-12 | |
| 2019-12-31 | $9.24M 10-K · filed 2022-03-22 | $0.00 10-K · filed 2020-03-26 |
| 2019-09-30 | $0.00 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $3.28M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $3.28M 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $3.28M 10-K · filed 2021-03-16 | |
| 2018-09-30 | $3.28M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $3.28M 10-Q · filed 2018-08-10 | |
| 2018-03-31 | $3.28M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $3.28M 10-K · filed 2020-03-26 | |
| 2017-09-30 | $3.28M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $3.28M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $3.28M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $3.28M 10-K · filed 2019-03-29 | |
| 2016-09-30 | $3.28M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $3.28M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $3.28M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $3.28M 10-K · filed 2018-03-30 | |
| 2015-09-30 | $3.28M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $3.28M 10-Q · filed 2015-08-19 | |
| 2015-03-31 | $3.30M 10-Q · filed 2015-05-20 | |
| 2014-12-31 | $3.47M 10-K · filed 2017-03-31 | |
| 2014-09-30 | $3.60M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $3.80M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $3.70M 10-Q · filed 2014-08-14 | |
| 2014-01-23 | $4.13M 10-Q · filed 2014-11-14 | |
| 2013-12-31 | $3.67M 10-K · filed 2016-03-30 | |
| 2012-12-31 | $3.59M 10-K · filed 2015-07-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |